TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04236128

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mobile App
Description: The app will be provided to patients in hospital on post-operative day 3. On the day of discharge, the patient will be emailed a Daily Health Check and receive subsequent Daily Health Check emails on Day 1-14, 21 and 30 days following discharge. The Daily Health Check is a tailored questionnaire to elicit their symptoms and status of post-operative recovery. After the patient has completed the Daily Health Check, a Daily Health Check Summary is emailed to the patient that summarizes their responses and provides appropriate action recommendations based on their responses ranging from: (i) suggestions for educational modules, (ii) expect a call from your health care team in the next 24 hours, (iii) call your surgeon's office today or (iv) go to the nearest emergency room. The patient's Daily Health Check responses are displayed in real time on a secure website that automatically red flags extreme responses to alert the health care team to contact the patient by telephone.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile App
Description: The app will be provided to patients in hospital on post-operative day 3. On the day of discharge, the patient will be emailed a Daily Health Check and receive subsequent Daily Health Check emails on Day 1-14, 21 and 30 days following discharge. The Daily Health Check is a tailored questionnaire to elicit their symptoms and status of post-operative recovery. After the patient has completed the Daily Health Check, a Daily Health Check Summary is emailed to the patient that summarizes their responses and provides appropriate action recommendations based on their responses ranging from: (i) suggestions for educational modules, (ii) expect a call from your health care team in the next 24 hours, (iii) call your surgeon's office today or (iv) go to the nearest emergency room. The patient's Daily Health Check responses are displayed in real time on a secure website that automatically red flags extreme responses to alert the health care team to contact the patient by telephone.
Study: NCT05708417

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Intervention
Description: The intervention in SDOI has the predominantly focus on each individual reflection and realisation and is built upon ACT' six core processes: 1) Acceptance, 2) Cognitive defusion 3) Being present, 4) Self as context, 5) Values, and 6) Committed action.~The program is based on up to 13 times attendance within the 12 months intervention period.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: No lifestyle intervention within the study, only test/datacollection
Study: NCT04892667

Intervention type: OTHER
Group type: OTHER
Intervention: Intervention
Description: Evaluation of the sensitivity of the cardiac uptake of 18F-FDG measured on D28 +/- 7 days, D42 +/- 7 days ou D56 + 4 days of the administration of ATCs to identify at 1 year the patients at risk of occurrence of a LVSD defined by a drop of more than 10 units of the LVEF and LVEF \&lt; 53%.~The patient participating in the study needs to respect a minimum of 12-hour fasting period, a high protein and a low-carbohydrate diet prior to performing PET/CT in order to limit physiological 18F-FDG myocardial fixation.
Study: NCT06609902

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Future Self-BD
Description: The Future Self group will attend 6 virtual sessions during which they will be encouraged to vividly generate personal and positive future events that they anticipate may be benefited by smoking cessation. All participants will complete the adjusting amount discounting task. All participants will also receive brief, CBT-based smoking cessation counseling. This group will involve one follow-up session one month after the sixth session. Each session will be conducted on HIPAA-compliant Zoom and led by the PI, Dr. Gold.
Study: NCT06081400

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cryoablation
Description: Percutaneous imaging-guided cryoablation

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy drug
Description: Either :~methotrexate 30mg/m² + vinblastine 6mg/m² (IV infusion) once/week for 6 months, then every other week from months 7 to 12, or vinorelbine 90mg/week (per os: 3x30mg, soft capsules) for 12 months.
Study: NCT06609902

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Daily Check-Ins
Description: The Daily Check-Ins (DCI) group will attend 6 virtual sessions during which they will complete the adjusting amount discounting task and receive brief, CBT-based smoking cessation counseling (consistent with counseling received by Future Self-BD). This group will involve one follow-up session one month after the sixth session. Each session will be conducted on HIPAA-compliant Zoom and led by the PI, Dr. Gold.
Study: NCT06217068

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Elliptical Activity
Description: 8 minutes of elliptical exercise at a moderate intensity based on heart rate reserve. There will be a 2-minute warm-up and 2-minute cool down period in addition to the 8 minutes at moderate-intensity.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Elliptical Activity
Description: 8 minutes of elliptical exercise at a moderate intensity based on heart rate reserve. There will be a 2-minute warm-up and 2-minute cool down period in addition to the 8 minutes at moderate-intensity.
Study: NCT06341517

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: iTBS
Description: Intermittent Theta Burst Stimulation (iTBS) pattern consisting of 2 s trains of 3 pulses at 50 Hz, repeated at 5 Hz, every 10s for a total of 600 pulses for up to 8 sessions daily for 5 days

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: iTBS
Description: Intermittent Theta Burst Stimulation (iTBS) pattern consisting of 2 s trains of 3 pulses at 50 Hz, repeated at 5 Hz, every 10s for a total of 600 pulses for up to 8 sessions daily for 5 days
Study: NCT06062888

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fresh Frozen Plasma (FFP)
Description: Standard of Care + 2 units (400-500 ml) of fresh frozen plasma
Study: NCT04429880

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxytocin
Description: Oxytocin given by intravenous route
Study: NCT06021652

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MindCotine Virtual reality
Description: Virtual reality platform
Study: NCT05324618

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tacrolimus
Description: 0.03% topical tacrolimus ointment applied on the affected areas twice daily for 4 months.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydrocortisone
Description: 1% hydrocortisone cream applied on the affected areas twice daily for 4 months.
Study: NCT06552247

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Fundus Picture AI testing
Description: G-Risk AI algorithm will assess the optic disc centered fundus picture and determine whether or not there is a need for referrable based on a pre-determined threshold (\>=0.73)
Study: NCT05953376

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcium Gluconate
Description: There will be 2 study arms, one will receive 2g IV calcium with the initial transfusion and the other will only receive calcium supplementation based on routine ionized calcium levels and/or physician discretion.
Study: NCT05401240

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: information reveal
Description: the experimental group will be informed that there will be an important examination about his/her cardiopulmonary fitness condition at the outpatient department (OPD)
Study: NCT04990687

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: gammaCore™
Description: Implantable VNS (iVNS), the electrical stimulation of the nervous system to modulate or modify function, has been FDA approved in the United States since the late 1990s. Implantable VNS therapy has been approved for use in epilepsy and depression.~When treating major depression with implanted VNS, the widely held belief is that chronic stimulation is required for therapeutic effect. In trials of implantable VNS in major depression, more patients respond at 12 months than at 3 months. Once depressed patients respond to VNS, the effects have been demonstrated to continue for up to five years with continued stimulation. This finding suggests that VNS gradually changes brain function through neuroplasticity.
Study: NCT05979194

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Labor Care Guide
Description: Identifying information and labor characteristics at admission, supportive care, care of the baby, care of the woman, labor progress, medication, and shared decision-making
Study: NCT04199416

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: mRehab app
Description: The mRehab app will be an interactive system with a user-friendly graphical user interface to provide multiple motivational functions that engage individuals in their prescribed home exercises. The app will contain video-based lower limb strengthening and aerobic exercise materials, health information, and motivational functions to increase their access to rehabilitation and care resources to augment their self-management ability.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham app
Description: The sham app will only contain educational components and text-based exercise recommendations.
Study: NCT06593405

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: occupational therapy interventions for low vision care
Description: Occupational therapists utilize many different treatment strategies when caring for the client with low vision. Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Interventions include task lighting, organizational strategies, smart apps, contrast, enlarged print, typoscopes and electronic magnification devices.
Study: NCT06662617

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: modified thoracoabdominal nerve block through perichondrial approach
Description: After the patient fell asleep, surgery was not yet started. Following sterile conditions for bilateral M-TAPA block application, the transducer was inserted on the chondrium in the sagittal plane at the 9-10th rib level. Subsequently, a deep angle was created with the probe for visualization of the underside of the costochondrium. The sonovisible needle tip was placed just below the chondrium and saline (5 ml) was injected for site confirmation. After the confirmation, 20 ml of 0.25% bupivacaine was administered for each group for a total of 40 ml of local anesthetic. Blocks were applied using an 80 mm sonovisible needle with a 6-10 MHz linear probe under the guidance of a portable ultrasound. Same procedure applied to the contralateral side.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Transversus Abdominal Plane block
Description: After the patient fell asleep, surgery was not yet started. Following sterile conditions for bilateral TAP block application, USG will be placed transversely on the mid-axillary line between the iliac crest and subcostal planes. Using the In Plane technique, the block needle will be advanced into the fascial plane between the internal oblique and transversus abdominis muscles and the location will be confirmed by administering 5 ml of saline . After the confirmation, 20 ml of 0.25% bupivacaine was administered for each group for a total of 40 ml of local anesthetic. Blocks were applied using an 80 mm sonovisible needle with a 6-10 MHz linear probe under the guidance of a portable ultrasound. Same procedure applied to the contralateral side.
Study: NCT06613334

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood test: measurement of plasma antipsychotic concentration
Description: Four blood tests are prospectively realized per patient during the study to measure the plasma concentration of antipsychotics (primary treatment: risperidone/paliperidone, olanzapine or aripiprazole). These blood samples are taken at the inclusion visit, at the follow-up visits 2 and 4 months after the inclusion visit, then at the end-of-study visit 6 months after the inclusion visit.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Voice interviews and questionnaires carried out via the CALLYOPE application
Description: Voice interviews carried out via the Callyope application: they consist of a series of tests, divided into two parts: Structured tasks (same content for each participant) and Semi-structured tasks (content varies for each participant).~The simultaneous analysis of several speech tasks allows us to break down the different stages of speech production and the important factors that influence its achievement.~In addition, patients will complete self-questionnaires via the application. Finally, lifestyle habits (sleep duration and number of steps) will be recorded via the application.~These different tests will be carried out on the application at the inclusion visit (M0), then every month (M1, M2, M3, M4, M5) until the end of study visit (M6).
Study: NCT06677684

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin A
Description: the intervention group received standard antibiotics plus adjunctive vitamin A supplementation (25,000 IU daily for two days)
Study: NCT06679387

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Memantine-HCl
Description: Memantine hydrochloride 20 mg once daily for 12 weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: A once daily matched tablet of placebo for 12 weeks
Study: NCT06679595

Intervention type: OTHER
Intervention: Pilot project paediatric transmural care
Description: The implementation of pilot projects for transmural care for chronically ill children

Intervention type: OTHER
Intervention: Pilot project paediatric transmural care
Description: The implementation of pilot projects for transmural care for chronically ill children

Intervention type: OTHER
Intervention: Pilot project paediatric transmural care
Description: The implementation of pilot projects for transmural care for chronically ill children
Study: NCT06677723

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: physical activity
Description: moderate-intensity running

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: physical activity
Description: moderate-intensity running
Study: NCT06678295

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy
Description: Twelve weekly sessions of individual cognitive behavioral therapy
Study: NCT06678451

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: When T2 appeared, the sugammadex group was given 2mg/kg of sugammadex intravenously (adjusted body weight), the neostigmine group was given 0.04mg/kg of neostigmine + 0.02mg/kg of atropine intravenously (adjusted body weight).

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neostigmine
Description: When T2 appeared, the neostigmine group was given 0.04mg/kg of neostigmine + 0.02mg/kg of atropine intravenously (adjusted body weight).
Study: NCT06622486

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EGL-001
Description: IV administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EGL-001
Description: IV administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EGL-001
Description: IV administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EGL-001
Description: IV administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EGL-001
Description: IV administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EGL-001
Description: IV administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EGL-001
Description: IV administration
Study: NCT01176331

Intervention type: PROCEDURE
Intervention: 20 and 23 gauge pars plana vitrectomy
Study: NCT01212705

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Adaptive servoventilation
Description: Background expiratory positive airway pressure with some inspiratory pressure support when needed
Study: NCT05872516

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Chang Gung Atrial Fibrillation Detecting Software
Description: This software is expected to be used in clinical testing to interpret the static 12-lead ECG of adults who are over 20 years old and suspected of having atrial fibrillation, detect whether there is a signal of atrial fibrillation, and output the results for clinicians Near-instant auxiliary diagnostic use.
Study: NCT05957094

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pharmacological agent: Citalopram
Description: Participants will be given 40 mg in capsule form, which is a normal clinical dose.
Study: NCT05900999

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Feasibility of idle time exercise
Description: The experiments in this proposal will assess the utility and subjective patient experience performing idle time exercise intervention designed to reduce learned non-use of the hemiparetic arm in the days, and weeks immediately following stroke. Exercise will be cued by wearable technology that provides vibrotactile cues similar to those provided by FitBit devices. Participants will be asked to perform simple exercises after receiving a vibration cue. In the first four sessions they will tap the more-involved wrist; in the second four sessions they will passively move the more-involved elbow through a range of motion; in the final four sessions they will actively move the more-involved elbow through a range of motion. Accelerometers in the wearable devices will monitor motion of the wrist during the exercise sessions. We will interview the participants two months later regarding how well they use the more-involved arm to perform daily activities.
Study: NCT05205941

Intervention type: DRUG
Group type: OTHER
Intervention: MMV688533
Description: Not exceeding 200mg
Study: NCT05543369

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elafibranor
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elafibranor
Description: Oral Tablet
Study: NCT05460130

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Simplified Hepatitis C Virus (HCV) Treatment Protocol
Description: A simplified, low-barrier, locally contextualized, HCV treatment protocol delivered by trained front-line health care providers (primary care physicians and mid-level providers) serving hard-to-reach-populations.
Study: NCT05957094

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will ingest a placebo (sugar pill) that is identical in appearance to the drug condition.
Study: NCT05921747

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard core stability exercise program
Description: The core stability exercises included Bridging, Pelvic rotation, Abdominal Tuck in, Knee to chest and Squatting. Pre and post measurement will be taken before and after the session.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard core stability exercise program
Description: The core stability exercises included Bridging, Pelvic rotation, Abdominal Tuck in, Knee to chest and Squatting. Pre and post measurement will be taken before and after the session.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Off-the-shelf virtual reality system
Description: HTC Vive (HTC Corporation, Bellevue, WA) VR Head-Mounted Display (110º field of view, 1080 × 1200 pixels/eye, 90 Hz refresh) along with the Vive hand controllers and trackers to provide an immersive VR experience. The Vive Tracker can be used to track limb and trunk position and motion while in a VR experience. This setup will be paired with a gaming computer with the power to run a VR experience at a high frame rate to mitigate the risk of motion sickness. KVET™( Karuna Virtual Embodiment Training) consists of 10-30 minute sessions of exercises in an embodied VR experience.
Study: NCT05611619

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Tyre noise - continuous flow
Description: Tyre noise from continuous traffic, throughout the night

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Tyre noise - continuous flow
Description: Tyre noise from continuous traffic, throughout the night

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Tyre noise - discrete events
Description: Tyre noise from few, discrete traffic events, occurring throughout the night

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Tyre noise - discrete events
Description: Tyre noise from few, discrete traffic events, occurring throughout the night

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: High noise level
Description: Tyre noise corresponding up to 65 dB LAEq,24h

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: High noise level
Description: Tyre noise corresponding up to 65 dB LAEq,24h

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Moderate noise level
Description: Tyre noise corresponding up to 60 dB LAEq,24h

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Moderate noise level
Description: Tyre noise corresponding up to 60 dB LAEq,24h

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Moderate noise level
Description: Tyre noise corresponding up to 60 dB LAEq,24h

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Moderate noise level
Description: Tyre noise corresponding up to 60 dB LAEq,24h

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Low noise level
Description: Tyre noise corresponding up to 55 dB LAEq,24h

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Low noise level
Description: Tyre noise corresponding up to 55 dB LAEq,24h

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Air-filled tyres
Description: Tyre noise from traditional, air-filled tyres

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Air-filled tyres
Description: Tyre noise from traditional, air-filled tyres

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Composite tyres
Description: Tyre noise from newly designed, airless composite tyres

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Composite tyres
Description: Tyre noise from newly designed, airless composite tyres
Study: NCT06263985

Intervention type: DEVICE
Group type: OTHER
Intervention: Axis Dermis biologic mesh repair for pelvic organ prolapse
Description: Subjects with pelvic organ prolapse will undergo a pelvic organ prolapse repair with the use of Axis Dermis biologic mesh.